SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

14 Jun 2023 07:00

RNS Number : 6184C
Victrex PLC
14 June 2023
 
 

14 June 2023

Victrex plc - Trading update

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which support CO2 reduction and bring environmental and societal benefit in multiple end-markets. Today's trading update covers the period ending 31 May 2023.

Year-to-date (YTD) Group volume & revenue

At the Group's interim results we signalled that, in line with the wider Chemical sector, ongoing macro-economic weakness and industrial customer destocking were impacting performance in several end markets. During the first half, Group volumes declined by 14%.

Whilst the Group remains ready to benefit from a macro-economic recovery, latest indicators suggest these current headwinds will now continue over the summer and at least until the end of FY 2023 in September.

Despite good progress in Medical, ongoing industrial headwinds mean YTD Group volumes are now tracking in excess of 20% down, compared to the record prior year. YTD Group revenue is tracking down by a mid-single digit percentage rate. If current run-rates continue, full year revenue would be down between 6%-10%.

For Q3 as a whole, we anticipate volumes will be approximately 800 tonnes (Q3 2022: 1,323 tonnes).

Outlook

In our Outlook at the interim results stage, we signalled that delivering full-year adjusted (pre-exceptional) profit before tax (PBT) in line with expectations assumed a step up in demand during the latter part of the second half, driven by macro-economic conditions.

Whilst we are seeing progress on gross margin, driven by pricing, sales mix, currency and easing energy costs, Group adjusted PBT to 31 May 2023 was approximately £53m. With no step up in demand going into the final quarter currently visible, and the resulting lower industrial revenue expectations, our full year adjusted PBT is now expected to be between £80m-£85m.  

Victrex will report its Q3 Interim Management Statement on Thursday 6 July 2023.

 

Analyst & investor conference call:

A conference call with management will take place this morning, 14 June 2023, at 08.00am BST. The call can be accessed via the following link:

 

https://services.choruscall.za.com/DiamondPassRegistration/register?confirmationNumber=2616372&linkSecurityString=6aee7987c

 

Inside information:

This announcement contains inside information. The person responsible for making this announcement is Jane Brisley, General Counsel & Company Secretary.

 

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations, Corporate Communications & ESG +44 (0) 7809 595831

Jakob Sigurdsson, Chief Executive +44 (0) 1253 897700

Ian Melling, Chief Financial Officer +44 (0) 1253 897700

 

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, provide environmental and societal benefit for customers and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUAAQUPWPGW
Date   Source Headline
30th Nov 20161:30 pmRNSTotal Voting Rights
17th Nov 20162:19 pmRNSDirector/PDMR Shareholding
10th Nov 201611:11 amRNSAdditional Listing
31st Oct 20162:39 pmRNSTotal Voting Rights
18th Oct 20162:10 pmRNSDirector/PDMR Shareholding
11th Oct 20167:00 amRNSTrading Statement
30th Sep 20161:11 pmRNSTotal Voting Rights
19th Sep 20164:28 pmRNSDirector/PDMR Shareholding
19th Sep 20163:18 pmRNSHolding(s) in Company
31st Aug 20169:28 amRNSTotal Voting Rights
17th Aug 20163:46 pmRNSDirector/PDMR Shareholding
29th Jul 20162:47 pmRNSTotal Voting Rights
28th Jul 20162:57 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Management Statement
19th Jul 20164:34 pmRNSDirector/PDMR Shareholding
30th Jun 201610:00 amRNSTotal Voting Rights
17th Jun 20163:56 pmRNSDirector/PDMR Shareholding
14th Jun 20164:42 pmRNSHolding(s) in Company
14th Jun 20164:24 pmRNSHolding(s) in Company
1st Jun 20169:02 amRNSBlock listing Interim Review
31st May 201611:42 amRNSTotal Voting Rights
26th May 20164:26 pmRNSHolding(s) in Company
17th May 20164:11 pmRNSDirector/PDMR Shareholding
16th May 20167:00 amRNSHalf-year Report
3rd May 20163:27 pmRNSHolding(s) in Company
3rd May 20163:15 pmRNSHolding(s) in Company
3rd May 20163:00 pmRNSHolding(s) in Company
29th Apr 201610:00 amRNSTotal Voting Rights
28th Apr 20167:00 amRNSResolution of US FTC inquiry
21st Apr 20167:00 amRNSDirector Declaration
19th Apr 201611:07 amRNSDirector/PDMR Shareholding
7th Apr 20167:00 amRNSTrading Statement
31st Mar 20162:51 pmRNSTotal Voting Rights
31st Mar 20161:45 pmRNSTotal Voting Rights
17th Mar 201610:15 amRNSDirector/PDMR Shareholding
1st Mar 20165:00 pmRNSDirector/PDMR Shareholding
29th Feb 20162:18 pmRNSTotal Voting Rights
26th Feb 20163:09 pmRNSHome Member State
17th Feb 201611:27 amRNSDirector/PDMR Shareholding
10th Feb 20163:55 pmRNSResult of AGM
10th Feb 20167:00 amRNSAGM Statement
9th Feb 20164:44 pmRNSHolding(s) in Company
5th Feb 20161:38 pmRNSGrant of Options
29th Jan 20169:27 amRNSTotal Voting Rights
19th Jan 201611:39 amRNSDirector/PDMR Shareholding
19th Jan 201610:08 amRNSDirector Declaration
5th Jan 201612:00 pmRNSAnnual Financial Report
31st Dec 201510:00 amRNSTotal Voting Rights
17th Dec 20154:23 pmRNSHolding(s) in Company
17th Dec 20153:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.